Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice

European Journal of Pharmacology

Volumn 560, Issue 1, 2007, Pages 36-41

  Sato, Tomoaki ^a   Ishida, Takayuki ^a   Irifune, Masahiro ^b   Tanaka, Koh ichi ^a   Hirate, Kenji ^c   Nakamura, Norifumi ^a   Nishikawa, Takashige ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Nippon Chemiphar Co Ltd   (Japan)

Author keywords

Arachidonic acid; Arginine vasopressin; Cyclooxygenase; Learning; Memory; NC 1900; Passive avoidance

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLTRIFUOROMETHYL KETONE; ARGIPRESSIN[4-9]; BAICALEIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DOCEBENONE; INDOMETACIN; LIPOXYGENASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NC 1900; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE A2 INHIBITOR; PIROXICAM; UNCLASSIFIED DRUG;

ADOLESCENT; AMNESIA; ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; LATENT PERIOD; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

AMNESIA; ANIMALS; ARACHIDONIC ACID; ARGININE VASOPRESSIN; AVOIDANCE LEARNING; CYCLOOXYGENASE 2; ENZYME INHIBITORS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY; MICE; OLIGOPEPTIDES; PYRROLIDONECARBOXYLIC ACID;

EID: 33847304970     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.011     Document Type: Article

References (38)

1. Ahmad A.S., Saleem S., Ahmad M., and Doré S. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol. Sci. 89 (2006) 265-270
2. Alexander S.P.H., Mathie A., and Peters J.A. TiPS nomenclature supplement. 12th ed (2001), Elsevier, London 67-102
3. Andreasson K.I., Kaufmann W.E., Worley P.F., Isakson P., and Markowska A.L. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J. Neurosci. 21 (2001) 8198-8209
4. 2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann. Neurol. 56 (2004) 24024-24028
5. Brinton R.E., Gehlert D.R., Wamsley J.K., Wan Y.P., and Yamamura H.I. Vasopressin metabolite, AVP4-9, binding sites in the brain distribution distinct from that of parent peptides. Life Sci. 38 (1986) 443-452
6. Brinton R.D., Gonzalez T.M., and Cheung W.S. Vasopressin-induced calcium signaling in cultured hippocampal neurons. Brain Res. 661 (1994) 274-282
7. Buccafusco J.J., Lapp C.A., Aronstam R.S., Hays A.C., and Shuster L.C. Role of prostanoids in the regulation of central cholinergic receptor sensitivity. J. Pharmacol. Exp. Ther. 266 (1993) 314-322
8. Burbach J.P.H., Kovacs G.L., De Wied D., Van Nispen J.W., and Greven H.M. A major metabolites of arginine-vasopressin in the brain is highly potent neuropeptides. Science 221 (1983) 1310-1312
9. 2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 87 (2002) 2851-2857
10. Courade J.P., Besse D., Delchambre C., Hanoun N., Hamon M., Eschalier A., Caussade F., and Cloarec A. Acetaminophen distribution in the rat central nervous system. Life Sci. 69 (2001) 1455-1464
11. De Wied D. Long term effect of vasopressin on the maintenance of conditioned avoidance response in rats. Nature 232 (1971) 58-60
12. De Wied D., Gaffori O., Van Ree J.M., and De Jong W. Central target for the behavioural effects of vasopressin neuropeptides. Nature 308 (1984) 276-278
13. Fujiwara M., Ohgami Y., Inada K., and Iwasaki K. Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats. Behav. Brain Res. 83 (1997) 91-96
14. 6]AVP(4-9) analogue, prevents the disruption of avoidance behavior. Behav. Brain Res. 83 (1997) 205-208
15. Hölscher C. Inhibitors of cyclooxygenases produce amnesia for a passive avoidance task in the chick. Eur. J. Neurosci. 7 (1995) 1360-1365
16. 2 produce amnesia for passive avoidance task in chick. Behav. Neural Biol. 61 (1994) 225-232
17. Hori E., Uwano T., Tamura R., Miyake N., Hishijo H., and Ono T. Effects of a novel arginine-vasopressin derivative, NC-1900, on the spatial memory impairment of rats with transient forebrain ischemia. Cogn. Brain Res. 13 (2002) 1-15
18. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., and Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2317-2321
19. 2 from rat liver. Mol. Cells 16 (2003) 361-367
20. 2. J. Neurosci. 7 (1987) 3783-3792
21. 2 EP2 receptor in cerebral ischemia. J. Neurosci. 24 (2004) 257-268
22. McGeer, P.L., McGeer, E.G. in press. NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies. Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2006.03.013.
23. 1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. Neuropharmacology 44 (2003) 541-552
24. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79 (1999) 1193-1226
25. Normandin M., Gagne J., Bernard J., Elie R., Miceli D., Baudry M., and Massicotte G. Involvement of the 12-lipoxygenase pathway of arachidonic acid metabolism in homosynaptic long-term depression of the rat hippocampus. Brain Res. 730 (1996) 40-46
26. 2 receptors activated by arginine vasopressin in rat hippocampal neurons. J. Biol. Chem. 274 (1999) 32762-32770
27. Pepicelli O., Fedele E., Berardi M., Raiteri M., Levi G., Greco A., Ajmone-Cat M.A., and Minghetti L. Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-d-aspartate receptors in rat hippocampus. J. Neurochem. 93 (2005) 1561-1567
28. Rall J., Mach S.A., and Dash P.K. Intrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats. Brain Res. 968 (2003) 273-276
29. Sanfeliu C., Hunt A., and Patel A. Exposure to N-methyl-d-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Res. 526 (1990) 241-248
30. Sato T., Tanaka K., Teramoto T., Ohnishi Y., Hirate K., Irifune M., and Nishikawa T. Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice. Peptides 25 (2004) 1139-1146
31. Sato T., Ishida T., Tanaka K., Chowdhury N., Irifune M., Hirate K., Mimura T., and Nishikawa T. Glutamate antagonists attenuate the action of NC-1900, a vasopressin fragment analog, on passive avoidance task performance in mice. Peptides 26 (2005) 893-897
32. Sharifzadeh M., Naghdi N., Khosrovani S., Ostad S.N., Sharifzadeh K., and Roghani A. Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats. Eur. J. Pharmacol. 511 (2005) 159-166
33. Sharifzadeh M., Tavasoli M., Soodi M., Mohammadi-Eraghi S., Ghahremani M.H., and Roghani A. A time course analysis of cyclooxygenase-2 suggests a role in spatial memory retrieval in rats. Neurosci. Res. 54 (2006) 171-179
34. Tanaka T., Yamada K., Senzaki K., Narimatsu H., Nishimura K., Kameyama T., and Nabeshima T. NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by β-amyloid protein in rats. Eur. J. Pharmacol. 352 (1998) 135-142
35. Teather L.A., Packard M.G., and Bazan N.G. Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation. Learn. Mem. 9 (2002) 41-47
36. Ueda H., Amano H., Shiomi H., and Takagi H. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice. Eur. J. Pharmacol. 56 (1979) 265-268
37. Williams J.H., Errington M.L., Lynch M.A., and Bliss T.V. Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 341 (1989) 739-742
38. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386